The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
LODESTAR: A single-arm phase II study of rucaparib in solid tumors with pathogenic germline or somatic variants in homologous recombination repair genes.
 
Sriram Anbil
Employment - University of Pennsylvania Health System
 
Nicholas Seewald
No Relationships to Disclose
 
E. Gabriela Chiorean
Consulting or Advisory Role - AADi; Astellas Pharma; BPGbio; Bristol-Myers Squibb/Celgene; IgM Biosciences; Ipsen; Merus; Pfizer; Purple Biotech; Regeneron; Takeda
Research Funding - Affini-T Therapeutics (Inst); BioAtla; Boehringer Ingelheim (Inst); Erasca, Inc (Inst); FibroGen (Inst); Genentech (Inst); Gilead/Forty Seven (Inst); Lonza (Inst); Merck (Inst); Mirati Therapeutics (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Merus
 
Maen Hussein
Consulting or Advisory Role - Abbvie; Aptitude Health; Aptitude Health; Aptitude Health; AstraZeneca; AstraZeneca; AstraZeneca; Athenex; AVEO; BeiGene; BMS; BMS; Coherus Biosciences; CTI BioPharma Corp; CTI BioPharma Corp; Exelixis; G1 Therapeutics; IntegraConnect; IntegraConnect; IntrinsiQ; ipsen; Karyopharm Therapeutics; Karyopharm Therapeutics; Karyopharm Therapeutics; Mirati Therapeutics; National Community Oncology Dispensing Association (NCODA); oncocyte
 
Pashtoon Kasi
Leadership - Precision Biosensors
Stock and Other Ownership Interests - Elicio Therapeutics
Consulting or Advisory Role - Astellas Pharma; Bayer; BeiGene; BostonGene; BostonGene; Daiichi Sankyo/Astra Zeneca; Delcath Systems; Eisai; Elicio Therapeutics; Exact Sciences; Foundation Medicine; Guardant Health; Illumina; Ipsen (Inst); Lilly; MSD Oncology; Natera; NeoGenomics Laboratories; QED Therapeutics; Regeneron; SAGA Diagnostics; Seagen; SERVIER; Taiho Oncology; Taiho Pharmaceutical (Inst); Tempus; Xilio Therapeutics
Research Funding - Advanced Accelerator Applications (Inst); Boston Scientific (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Douglas Laux
No Relationships to Disclose
 
Gary Schwartz
Stock and Other Ownership Interests - Bionaut Labs; GenCirq
Consulting or Advisory Role - Bionaut Labs; Concarlo; Ipsen; OnCusp Therapeutics; PTC Therapeutics; Ratiopharm
Patents, Royalties, Other Intellectual Property - Companion diagnostics for CD4 inhibitors (Inst); patent granted to develop a new technology called PNAs for cancer therapy
 
Geoffrey Shapiro
Consulting or Advisory Role - Bicycle Therapeutics; Merck Serono; Xinthera
Research Funding - Bristol-Myers Squibb/Medarex (Inst); Lilly (Inst); Merck (Inst); Merck Serono (Inst); Pfizer (Inst); Tango Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent # 10,934,593 B2 Compositions and methods for predicting response and resistance to CDK4/6 inhibition; Patent #: 9872874 Title: Dosage regimen for sapacitabine and seliciclib Issue Date: 1/23/2018
 
Kevin Lin
Employment - Revolution Medicines
Stock and Other Ownership Interests - Revolution Medicines
Travel, Accommodations, Expenses - Revolution Medicines
 
Marcia Craib
Employment - pharma&
 
Lara Maloney
Employment - Clovis Oncology
Leadership - pharma&
 
Karen McLachlan
Employment - Clovis Oncology
Stock and Other Ownership Interests - Clovis Oncology
 
Hanna Tukachinsky
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Alexa Schrock
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine; Roche
 
Shuoguo Wang
Stock and Other Ownership Interests - Foundation Medicine
 
Ethan Sokol
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Brennan Decker
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Foundation Medicine
 
Katherine Nathanson
Consulting or Advisory Role - Merck
 
Susan Domchek
Honoraria - Intellia Therapeutics
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst)
 
Kim Reiss
Honoraria - MJH Life Sciences
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Carisma Therapeutics; Foundation Medicine; Guardant Health; Merus NV; MOMA Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Clovis Oncology; GlaxoSmithKline (Inst); Lilly (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from invention (I)
Expert Testimony - Elmhurst Hospital; NYU School of Medicine